BRIEF-Microport Scientific Says Shanghai Microport Endovascular Medtech Sees Increase In FY Profit

Reuters01-29

Jan 29 (Reuters) - Microport Scientific Corp :

* SHANGHAI MICROPORT ENDOVASCULAR MEDTECH SEES INCREASE IN FY PROFIT

* SEES FY OPERATING REVENUE OF SHANGHAI MICROPORT ENDOVASCULAR MEDTECH (GROUP) RMB1,174.4155 MILLION AND RMB1,201.3105 MILLION

* SEES FY NET PROFIT ATTRIBUTABLE BETWEEN RMB474.6484 MILLION AND RMB492.4923 MILLION FOR SHANGHAI MICROPORT ENDOVASCULAR MEDTECH

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment